AARD News

AARDVARK THERAPEUTICS, INC. (AARD) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Aardvark Therapeutics, Inc. Investors of Upcoming Deadline

Important Notice to Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Beta Bionics, Inc. (NASDAQ: BBNX); PROCEPT BioRobotics Corporation (NASDAQ: PRCT); and The Simply Good Foods Company (NASDAQ: SMPL): Grabar Law Office is

Shareholders of Aardvark Therapeutics, Inc. (AARD): Protect Your Rights Before October 13, 2026 - Contact Levi & Korsinsky

Securities Lawsuit Alert: Aardvark Therapeutics, Inc. (AARD) - Contact Levi & Korsinsky Before October 13, 2026

Investors Urged to Contact Levi & Korsinsky for Information Before October 13, 2026 - Aardvark Therapeutics, Inc. (AARD)

Pomerantz LLP Files Securities Class Action Lawsuit Against Aardvark Therapeutics, Inc. – AARD

AARD Deadline: AARD Investors with Losses in Excess of $100K Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit

Deadline Alert: Aardvark Therapeutics, Inc. (AARD) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

AARD Investor Notice: Hagens Berman Alerts Investors in Aardvark Therapeutics (NASDAQ: AARD) to Filing of Securities Fraud Class Action

AARD CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Aardvark (AARD) Investors of Securities Class Action Lawsuit Deadline on October 13, 2026 Ready to Announce with Confidence?